Close Menu
    What's Hot

    Editor’s Letter – Volume 2, Issue 5, May 2026

    May 13, 2026

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026

    Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

    May 13, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Will the US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?

      April 22, 2026

      Daiichi Life to Reinsure Whole Life Block with Prismic Life

      April 13, 2026

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      Life Settlement Secondary Market Returns to Growth but Plenty of Untapped Potential Still Remains

      April 22, 2026

      EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

      March 25, 2026

      Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

      May 13, 2026
      Just Group

      Safe Computing Pension Fund Completes Bulk Purchase Annuity Buy-In With Just Group

      May 11, 2026

      Bakkavor Pension Scheme Completes Bulk Purchase Annuity Buy-In With Rothesay

      May 5, 2026
      Bank of England

      Prudential Regulation Authority Publishes New Funded Reinsurance Regulations

      April 29, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

      March 25, 2026

      Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

      March 25, 2026

      Latest CMI Model Shows Further Rise in Cohort Life Expectancy

      March 11, 2026

      Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

      May 13, 2026

      Two Years On, PHL Variable Saga Approaches Conclusion

      May 13, 2026

      UK Equity Release Market Origination Slows To Begin 2026

      May 6, 2026

      CHIP Mortgage Trust Issues C$200m of Medium-Term Notes

      April 29, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

      May 13, 2026

      Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

      May 13, 2026

      Two Years On, PHL Variable Saga Approaches Conclusion

      May 13, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Q&A: Chris Wells, Managing Editor, Longevity and Mortality Investor

    Life Insurance October 8, 2025By Greg Winterton
    Share
    Twitter LinkedIn Email

    Longevity and Mortality Investor (LMI) is the new name for Life Risk News. Greg Winterton caught up with Chris Wells, Managing Editor at LMI, to discuss the reasons behind the rebrand, his thoughts on how the longevity and mortality markets have evolved in recent years, and plans for the future. 

    GW: Chris, let’s start with the obvious. Why is the magazine re-branding? 

    CW: The decision to rebrand Life Risk News to Longevity and Mortality Investor reflects the evolution of the space in the past few years. When we began, we wanted, in part, to highlight the multitude of markets where either longevity risk or mortality risk was present. But increasingly, the capital markets are taking a more strategic approach to this space – just look at the reports of North American investors buying UK insurers in the pension risk transfer market, for example. The new name/brand is designed to better align our coverage with how the market is behaving. 

    GW: Will there be any significant changes to the output of the magazine? 

    CW: That depends on how you define significant. We will still be covering everything we currently do, but there will be more of it, and we’ll be tweaking the focus to be a little tighter in terms of being more investor-oriented than generalist oriented. There will also be visual changes to the website and the email newsletter, but these are branding changes of course, as opposed to content-related ones. 

    GW: What is your main observation about how this space has evolved since you launched Life Risk News back in 2022? 

    CW: The blurring of the lines between annuity/life insurers and asset managers. We’ve seen a few instances of large, brand-name alternative investment firms buying or partnering with life insurers in a few different ways. While their motivation is access to premium payments that they can use to invest, the growth in the aggregate dollar amount that the annuity/life/asset manager Venn diagram manages compared to just a couple of years ago is significant. Secondly, there has been a notable resilience of established secondary life markets such as life settlements, structured settlements and equity release. Even with rates at historical highs these markets have demonstrated continued utility to consumers looking to release liquidity from private assets and continued support from the capital markets to provide this.  

    GW: When you originally launched Life Risk News, one of the reasons was to provide free-to-air educational content aimed at capital allocators, largely due to the lack of it at the time. Will that change at all? 

    CW: No, quite the opposite, actually. Something else that has struck me since we began this endeavour is that the education level that investors have in terms of alternative credit allocations such as life settlements and life ILS when compared to, say, direct lending, needs to rise. LMI plans to continue to raise awareness of the features and benefits of these asset classes, although how we deliver that insight might adjust in the medium term. 

    GW: Are there any other tangential products or services that LMI will offer as part of the re-brand? 

    CW: In the short term, no, in the medium term, yes. The short term for us runs through next May, when in London on Tuesday 19th May 2026, we will host the Longevity and Mortality Investor Conference, a rebrand of our Life ILS Conference, the magazine’s flagship event. We’re tweaking the format of this event to align more closely with the magazine’s coverage and mission. 

    In the medium term, then yes; we’re looking at webinars, reports, partnerships and other event opportunities. But there are no defined deadlines for those as of yet, and we’re very much focused on executing the changes we’re making to the magazine to a high level at the moment. 

    GW: Lastly, Chris, what is your final message to the reader? 

    CW: Firstly, we appreciate all the support we have received so far from a range of participants in the longevity and mortality markets. We’ve been afforded a lot of time and help by many people and firms. And second, we hope our readers are as excited about the way forward as we are. We think that the longevity and mortality markets represent a multi-trillion-dollar opportunity for capital markets investors in the coming decade or so and we look forward to covering the themes and topics that are of most interest to buyers and sellers of longevity and mortality risk-based assets in the years to come; we’re always open to feedback, suggestions and requests.  

    Chris Wells is Managing Editor of Longevity and Mortality Investor 

    2025 - October Alternative Credit Alternative Risk Transfer Bulk Purchase Annuity Transactions Clinical Mortality Equity Release / Reverse Mortgages Life Contingent Structured Settlements Life ILS Life Insurance Insurtech Life Settlement Litigation Life Settlements Longevity Risk Mortality Risk Pension Risk Transfer Population Mortality Q&A Regulation Technology Volume 1 Issue 1 – October 2025
    Share. Twitter LinkedIn Email

    Related Posts

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026By Mark McCord

    Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

    May 13, 2026By Greg Winterton

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026By Greg Winterton

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026By Dr. Jyotsna Kamble
    Latest Issue

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026

    Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

    May 13, 2026

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.